Practically every electronic product today contains one or more analog-to-digital converters (ADCs). As an engineer, you have no doubt already encountered the ADC in a design project. If not, then you ...
Synaffix, a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), licensed its ADC technology to BigHat Biosciences ...
As much as it’s an analog world, it is often being chopped up into digital pieces. As communications go digital and the computing power increases, signals are being transformed into digital words that ...
Zacks Investment Research on MSN
ADC Therapeutics (ADCT) upgraded to buy: Here's why
ADC Therapeutics SA (ADCT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
In this series, I have written eleven articles (see reference section) about the AC performance of systems with SAR-ADCs and delta-sigma ADCs. The target applications were sensor-based that, ...
Explore how digital feedback controllers manage motors, pressure, temperature, and more, and learn why ADC and DAC performance are crucial when designing robust embedded systems. How to define the ...
The FDA has granted a priority review to ADC Therapeutics’ antibody-drug conjugate (ADC) Lonca in the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL). ADC is set to learn ...
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores Lonza's commitment to helping customers deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback